GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **651 - 675** of **4050** in total

« First

‹ Prev

…

23

24

25

26

27

28

29

30

31

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G82779CI	43
IgM	Patient 3	-180	mild	G82779CI	80
IgA	Patient 3	4	mild	G82779CI	413
IgG	Patient 3	11	mild	G82779CI	82
IgG	Patient 3	4	mild	G82779CI	73
IgM	Patient 3	11	mild	G82779CI	217
IgM	Patient 3	4	mild	G82779CI	199
IgA	Patient 4	12	mild	G82779CI	370
IgG	Patient 4	12	mild	G82779CI	152
IgM	Patient 4	12	mild	G82779CI	290
IgA	Patient 1	10	moderate	G82348BZ	402
IgA	Patient 1	22	moderate	G82348BZ	410
IgA	Patient 1	6	moderate	G82348BZ	295
IgG	Patient 1	10	moderate	G82348BZ	32
IgG	Patient 1	22	moderate	G82348BZ	43
IgM	Patient 1	10	moderate	G82348BZ	51
IgM	Patient 1	22	moderate	G82348BZ	199
IgG	Patient 1	6	moderate	G82348BZ	26
IgM	Patient 1	6	moderate	G82348BZ	37
IgA	Patient 2	15	mild	G82348BZ	311
IgA	Patient 2	24	mild	G82348BZ	358
IgG	Patient 2	15	mild	G82348BZ	31
IgG	Patient 2	24	mild	G82348BZ	32
IgM	Patient 2	15	mild	G82348BZ	111
IgA	Patient 2	3	mild	G82348BZ	340